Endometriosis Trial, Recruiting NCT07523997 Sponsor: University of Edinburgh Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07523997
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have long-term pelvic pain (lasting a long time, not just occasionally)
  • Your doctor has diagnosed you with likely endometriosis based on an examination or scan, and you are already scheduled to have a keyhole surgery (laparoscopy) to confirm this within the next four months

Who may not be able to join:

  • You are unable to give your consent to take part, or you do not wish to give consent
  • You are currently trying to get pregnant, are pregnant, or are breastfeeding
  • You have gone through menopause (no periods for more than 12 months and not taking hormonal treatments to manage this, or have had both ovaries removed)
  • You have previously had a hysterectomy (surgery to remove the womb)
  • You have been diagnosed with, or there is a suspicion of, cancer in your pelvis
  • You cannot have an MRI scan — for example, because you have metal implants in your body, a medical device implanted, or you experience severe claustrophobia (fear of enclosed spaces)
  • You cannot take a medication called Buscopan — for example, if you have glaucoma, heart problems, an irregular heartbeat, a muscle condition called myasthenia, or have had a bad reaction to Buscopan before (confirm with trial site)
  • You are currently taking part in another clinical drug trial or certain other interventional research studies (confirm with trial site)
  • You have previously had a severe infection of the pelvic organs (severe pelvic inflammatory disease)
  • You have previously had peritonitis (a serious infection or inflammation inside the abdomen)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lucy HR Whitaker, MD, University of Edinburgh

Phone: 01316518321

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Edinburgh
Registry
ClinicalTrials.gov
Start date
8 April 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

In vivo uptake of 18F-GP1 and 68Ga-FAPI in endometriosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov